GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Artificial Intelligence /Machine learning (ML) in GI Endoscopy

Machine learning (ML) in GI Endoscopy

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated October 1, 2025

Quick Answer

Machine learning (ML) in gastrointestinal (GI) endoscopy is revolutionizing the field by improving diagnostic precision, reducing human variability, and enhancing workflow efficiency. Here is a detailed explanation of the role, applications, challenges, and future outlook for ML in GI endoscopy: ### Key Benefits of ML in GI Endoscopy: 1.


Machine learning (ML) in gastrointestinal (GI) endoscopy is revolutionizing the field by improving diagnostic precision, reducing human variability, and enhancing workflow efficiency. Here is a detailed explanation of the role, applications, challenges, and future outlook for ML in GI endoscopy:

### Key Benefits of ML in GI Endoscopy:

1. **Enhanced Diagnostic Precision**:

  • ML algorithms, particularly deep learning models, can analyze endoscopic images with greater accuracy than conventional methods.
  • They excel in detecting, classifying, and predicting gastrointestinal diseases, including polyps, adenomas, and cancers.

2. **Reduction of Human Variability**:

  • Inter-operator variability in lesion detection and diagnosis is a common challenge in endoscopy.
  • ML ensures more consistent and standardized results across different clinical settings, leading to improved diagnostic reliability.

### Core Applications of ML in GI Endoscopy:

ML is utilized in four primary domains:

1. **Computer-Assisted Detection (CADe)**:

  • CADe systems use deep convolutional neural networks (CNNs) like ENDO-AID and RetinaNet to identify lesions in real-time during endoscopy.
  • These systems have improved adenoma detection rates by 7–10%, significantly reducing missed lesions during colonoscopy.

2. **Computer-Assisted Diagnosis (CADx)**:

  • CADx models help classify lesions and predict their malignancy, aiding in the accurate diagnosis of GI diseases.
  • Algorithms such as XGBoost and CatBoost have been used to predict outcomes like polyp recurrence and gastrointestinal bleeding risks, outperforming traditional statistical models.

3. **Therapeutic Assistance**:

  • ML tools guide therapeutic interventions, such as polyp removal or biopsy, by identifying optimal treatment strategies based on real-time data.

4. **Technical Support for Workflow Efficiency**:

  • ML systems optimize workflow by automating processes like image analysis, annotation, and report generation, reducing the burden on clinicians and improving efficiency in busy endoscopy suites.

### Challenges in ML Implementation:

1. **Heterogeneity of GI Diseases**:

  • The diversity of gastrointestinal diseases and demographic variations across populations make it difficult for ML algorithms to generalize effectively.
  • Algorithms trained on limited datasets may perform poorly in diverse clinical settings.

2. **Dataset Quality and Bias**:

  • Retrospective data is commonly used for training, which can introduce selection and spectrum biases, reducing model reliability in real-world practice.
  • High-quality, diverse, and annotated datasets are essential for robust ML training.

3. **Annotation Bottleneck**:

  • Creating large, expert-annotated datasets is time-consuming and expensive.
  • Tools like Label Studio and Segment Anything Model (SAM) help automate and accelerate the annotation process, improving efficiency.

4. **Image Artefacts and Reflections**:

  • Artefacts and reflections in endoscopic images can distort model training and predictions.
  • Techniques like CLAHE (Contrast Limited Adaptive Histogram Equalization), data augmentation, and transformer networks enhance image clarity and model robustness.

5. **Real-Time Integration Limitations**:

  • Deploying ML systems in real-time during endoscopy faces technical hurdles, including data latency, limited computational resources, and integration challenges in busy clinical environments.

6. **Ethical and Privacy Concerns**:

  • Compliance with regulations like GDPR ensures ethical data usage, anonymization, informed consent, and transparency in AI-assisted diagnostics.
  • Algorithmic bias and inequitable outcomes must be addressed to ensure fairness.

7. **Cost–Accuracy Trade-off**:

  • Using junior endoscopists for data annotation reduces costs but may compromise accuracy.
  • Combining junior and expert reviewers provides a balanced, cost-effective approach.

### Explainability and Clinician Trust:

  • **Explainable Artificial Intelligence (XAI)** tools like SHAP (SHapley Additive exPlanations) and saliency maps are crucial for clinician trust.
  • These methods make ML decisions interpretable, allowing clinicians to understand and act on AI-generated insights.

### Future Outlook:

1. **Integration of Large Language Models (LLMs)**:

  • The combination of LLMs and computer vision systems is expected to further enhance diagnostic accuracy, workflow efficiency, and patient-centric care in GI endoscopy.

2. **Standardisation and Collaboration**:

  • Standardized data protocols and interdisciplinary collaboration among clinicians, engineers, and regulators are essential for developing reliable and scalable ML systems.

3. **Clinician Training**:

  • Endoscopists need specialized training to interpret AI outputs, handle false positives, and integrate ML tools effectively into clinical workflows.

4. **Global Applicability**:

  • Models trained on diverse, multi-regional datasets can generalize better to global populations, ensuring equitable and effective diagnostic solutions.

### Conclusion:

Machine learning is transforming GI endoscopy into a more precise, efficient, and patient-centred diagnostic field. While challenges like data heterogeneity, bias, and real-time integration exist, advancements in technology, collaboration, and ethical practices are paving the way for widespread adoption. With the integration of large language models and computer vision systems, ML has the potential to redefine the future of gastrointestinal healthcare.

Related Q&A

AI and U.S. Healthcare Costs: NEJM Catalyst | July 2026

Introduction: Artificial intelligence is rapidly transforming healthcare through drug discovery, clinical decision support, remote monitoring, and administrative automation. While AI is widely expected to reduce healthcare costs, this perspective argues that current payment models and...

Large AI Models and Healthcare: Nature Medicine | June 2026

Introduction: Large frontier AI models such as GPT-5 and Gemini have achieved impressive results across numerous healthcare benchmarks. However, high benchmark scores alone may not reflect real-world clinical reliability. This study systematically evaluated the robustness...

AI Ethics From Silicon Valley to the Vatican: JAMA | July 2026

Introduction: Artificial intelligence is rapidly transforming medicine, but its influence extends far beyond healthcare. This JAMA AI Conversations article explores how AI ethics has become a global societal issue, engaging technology leaders, policymakers, healthcare professionals,...

Physician-Complementing AI in Oncology: The ASCO Post | June 2026

Introduction: Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise....

AI-Based Clinical Trial End Points: A New Era in Drug Development: NEJM AI | July 2026

Introduction Clinical trial endpoints have traditionally relied on expert human interpretation, particularly for pathology-based outcomes. However, variability between observers, cost, and time remain important limitations. This NEJM AI perspective discusses how artificial intelligence is beginning...

Medical AI Assistant: Publication or Medical Device?: NEJM AI | July 2026

Introduction: As artificial intelligence becomes increasingly integrated into clinical practice, an important question arises: should AI assistants be regulated as medical devices or viewed as evidence-based clinical methodologies? This NEJM AI perspective proposes a new...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer